The European Molecular Biology Laboratory (EMBL) has long been a pioneer in developing and applying Artificial Intelligence (AI) to advance genomics, structural biology, and drug discovery. One of the ...

Encouraged by these results, Dudin, Dey, Guichard, and Hamel launched a close collaboration. Three years later, their work has produced near-encyclopedic insight into hundreds of protist species and ...

VU LSC-EMBL Partnership for Genome Editing Technologies has the following research output in the current window (1 October 2024 - 30 September 2025) of the Nature Index. Click on Count to view a list ...

EMBL researchers created SDR-seq, a next-generation tool that decodes both DNA and RNA from the same cell. It finally opens access to non-coding regions, where most disease-associated genetic variants ...

A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...